A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults w/ADHD

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2018 - February 27, 2021